Speech Therapy: Clinical Trials

8 trials of Speech Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 8 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Completed 3, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 13Completed 2, Terminated 1

Follow Speech Therapy: new trials by email Literature Review of Speech Therapy trials Research Report on Speech Therapy

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter
Psilocybin, Speech therapy - Stuttering
Phase 2Not yet recruitingNYU Langone Health252026-01-152025-12-22
A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid
Amantadine, Physical, Occupational, Speech Therapy, Provider Counseling - Long COVID, Post-Acute COVID-19 Syndrome
Phase 2WithdrawnUniversity of Texas Southwestern Medical Center2025-06-012025-08-26
Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia
Transcranial Magnetic Stimulation (TMS), Speech-Language Therapy (SLT) - Aphasia, Stroke
Phase 2RecruitingUniversity of Pennsylvania242025-02-112026-03-05
Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders
tDCS or Transcranial Direct Current Stimulation, Risperidone, Sham tDCS - Attention, Visual Perceptual Weakness
Phase 1 / Phase 2CompletedSpanish Foundation for Neurometrics Development1802024-04-012026-09-10
Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia
Famotidine, Speech Language Therapy - Laryngomalacia, Gastro Esophageal Reflux
Phase 1 / Phase 2TerminatedReema Padia652020-11-182025-07-20
Dextroamphetamine and tDCS to Improve the Fluency
Dexedrine, Active tDCS, Speech Therapy - Stroke
Phase 2CompletedThe University of Texas Health Science Center, Houston102015-03-012018-08-03
Swallowing Rehabilitation of Dysphagic Tracheostomized Patients Under Mechanical Ventilation at ICU
speech therapy - Dysphagia
Phase 2UnknownFederal University of São Paulo302008-01-012011-12-21
The Development of Autistic Children Based on Mothers´Response in Autism Behavior Checklist
Speech Therapy - Autism, Asperger Syndrome
Phase 1 / Phase 2CompletedFederal University of São Paulo112006-03-012008-08-01

Conditions studied

Stroke (2)  ·  Aphasia (1)  ·  Asperger Syndrome (1)  ·  Autistic Disorder (1)  ·  Communication Disorders (1)  ·  Deglutition Disorders (1)  ·  Gastroesophageal Reflux (1)  ·  Laryngomalacia (1)  ·  Post-Acute COVID-19 Syndrome (1)  ·  Social Behavior (1)  ·  Stuttering (1)

Sponsors

Federal University of São Paulo (2)  ·  NYU Langone Health (1)  ·  Reema Padia (1)  ·  Spanish Foundation for Neurometrics Development (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of Pennsylvania (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (6)  ·  Brazil (2)

Top investigators

Amy Mathews, M.D. (1)  ·  Ana Carina Tamanaha, Student (1)  ·  Gerard E Francisco, MD (1)  ·  H. Branch Coslett, MD (1)  ·  Katia Alonso, PHD (1)  ·  Michael Bogenschutz, MD (1)  ·  Reema Padia, MD (1)

Results publications

PMID 25468234, PMID 27173384, PMID 29625151, PMID 33578648, PMID 33658971, PMID 33823927, PMID 35734582, PMID 37445385, PMID 40762274

NIH funding

R21DC021833 (1)